Overview

Study to Assess Bronchospasm Potentially Induced by HFO vs HFA MDI in Participants With Well/Partially Controlled Asthma

Status:
Not yet recruiting
Trial end date:
2023-09-25
Target enrollment:
Participant gender:
Summary
A study to assess bronchospasm potentially induced by HFO MDI as compared with HFA MDI in participants with well controlled or partially controlled asthma
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca